← Back to Search

Social Network Strategy + COVID-19 messaging for Coronavirus (C3 Trial)

N/A

Waitlist Available

Led By John Schneider, MD

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

C3 Trial Summary

This trial will implement and evaluate a COVID-19 testing and vaccination approach that combines an evidence-based Social Network Testing Strategy (SNS) with community developed COVID-19 public health messages (SNS+). The trial will engage two disenfranchised populations across rural and urban sites in states across the Central US (Texas (TX), Louisiana (LA), Arkansas (AR), Indiana (IN), Illinois (IL)). 2400 people will be recruited, enrolled and tested. The focus is on two communities most impacted by COVID-19: 1) Criminal justice involved (CJI) - non-incarcerated people with previous history of arrest

Eligible Conditions

Coronavirus

C3 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Total number of tests among network members referred for COVID testing (network tested).

Total number of vaccinations among study participants given COVID vaccine information (number vaccinated)

C3 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Social Network Strategy + MessagingExperimental Treatment1 Intervention

Study staff will describe the Social Network Strategy, construct a plan for successfully referring network members into the study, and discuss compensation for the recruitment efforts. Study staff will specifically discuss network members of interest: "friend, family, coworker or someone you spend time with on a regular basis". Walk through and scenario play will be strategies to assist with planning regarding: (1) how the conversation will be raised, (2) how potential barriers to testing will be addressed, (3) how the screening by phone or web survey will be conducted, (4) how network members will have the option to bring others into the study visit with them, (5) what information about the study will be shared. Finally, community developed COVID-19 public health messages will be shared in the participant's preferred language.

Group II: Social Network Strategy (SNS Condition)Active Control1 Intervention

Study staff will describe the Social Network Strategy, construct a plan for successfully referring network members into the study, and discuss compensation for the recruitment efforts. Study staff will specifically discuss network members of interest: "friend, family, coworker or someone you spend time with on a regular basis". Walkthrough and scenario play will be strategies to assist with planning regarding: (1) how the conversation will be raised, (2) how potential barriers to testing will be addressed, (3) how the screening by phone or web survey will be conducted, (4) how network members will have the option to bring others into the study visit with them, (5) what information about the study will be shared.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NORC at the University of ChicagoOTHER

4 Previous Clinical Trials

428,025 Total Patients Enrolled

Better Community Development, Inc. (BCD)UNKNOWN

Capitol Area Reentry Program (CARP)UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have signed up for this medical experiment?

"Affirmative. The information available on clinicaltrials.gov shows that this research is actively seeking out participants. It was first posted on April 29th, 2021 and last updated on March 10th 2022; 2400 people are necessary for the trial's success at a single site."

Answered by AI

Are there any remaining openings in this medical experiment?

"According to the clinicaltrials.gov database, this research study is actively recruiting participants with its first post dated on April 29th 2021 and most recent amendment occurring March 10th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US

2021. "Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04743908.